In vitro anti-inflammatory effects of AZD8999, a novel bifunctional muscarinic acetylcholine receptor antagonist /β2-adrenoceptor agonist (MABA) compound in neutrophils from COPD patients

Recent evidence indicates that AZD8999 (LAS190792), a novel muscarinic acetylcholine receptor antagonist and β2-adrenoceptor agonist (MABA) in development for chronic respiratory diseases, induces potent and sustained relaxant effects in human bronchi by adressing both muscarinic acetylcholine recep...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:PLoS One
Auteurs principaux: Milara, Javier, Contreras, Sonia, de Diego, Alfredo, Calbet, Marta, Aparici, Mònica, Morcillo, Esteban, Miralpeix, Montserrat, Cortijo, Julio
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2019
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6319735/
https://ncbi.nlm.nih.gov/pubmed/30608978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0210188
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires